Other
Unrecognized compensation cost related to non-vested awards
Moderna Unrecognized compensation cost related to non-vested awards increased by 27.0% to $978M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 11.1%, from $1.1B to $978M.
Analysis
StatementBalance Sheet Statement
SectionOther
First reportedQ1 2019
Last reportedQ1 2026May 1, 2026
Metric ID:
other_employee_service_share_based_compensation_nonveste_67563fHistorical Data
15 periods
| Q2 '21 | Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $336M | $348M | $538M | $575M | $529M | $789M | $743M | $701M | $1.2B | $1B | $875M | $1.1B | $908M | $770M | $978M |
| QoQ Change | — | +3.6% | +54.6% | +6.9% | -8.0% | +49.1% | -5.8% | -5.7% | +71.2% | -16.7% | -12.5% | +25.7% | -17.5% | -15.2% | +27.0% |
| YoY Change | — | — | — | +71.1% | +52.0% | +46.7% | +29.2% | +32.5% | +52.1% | +34.6% | +24.8% | -8.3% | -9.2% | -12.0% | -11.1% |
Range$336M – $1.2B
CAGR+35.7%
Avg YoY Growth+25.2%
Median YoY Growth+30.9%
Unrecognized compensation cost related to non-vested awards at Other Companies
Frequently Asked Questions
- What is Moderna's unrecognized compensation cost related to non-vested awards?
- Moderna (MRNA) reported unrecognized compensation cost related to non-vested awards of $978M in Q1 2026.
- How has Moderna's unrecognized compensation cost related to non-vested awards changed year-over-year?
- Moderna's unrecognized compensation cost related to non-vested awards decreased by 11.1% year-over-year, from $1.1B to $978M.